Published in Biomark Res on April 08, 2017
The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2006) 13.01
Babesiosis. Clin Microbiol Rev (2000) 3.97
Human babesiosis. N Engl J Med (2012) 3.91
Autoimmune hemolytic anemia. Am J Hematol (2002) 3.01
Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA (1996) 2.88
Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med (2011) 2.64
Human babesiosis. Ann Trop Med Parasitol (1998) 2.24
Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis (2001) 1.89
Persistent parasitemia after acute babesiosis. N Engl J Med (1998) 1.81
A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med (1996) 1.64
Piroplasmosis in man; report of a case. Doc Med Geogr Trop (1957) 1.48
Single-dose prophylaxis against Lyme disease. Lancet Infect Dis (2007) 1.45
Clinical observations on Babesia gibsoni and Babesia canis infections in dogs. J Am Vet Med Assoc (1982) 1.41
Treatment of autoimmune hemolytic anemias. Haematologica (2014) 1.33
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood (2014) 1.22
Kala-azar associated with coombs-positive autoimmune hemolytic anemia in the patients coming from the endemic area of this disease and successful treatment of these patients with liposomal amphotericin B. Pediatr Hematol Oncol (2005) 1.16
Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review. JAMA (2016) 1.04
Clinical picture: human babesiosis. Lancet (2001) 1.02
A physician's guide to transfusion in autoimmune haemolytic anaemia. Br J Haematol (2004) 0.97
Autoimmune hemolysis in malaria: a report of three cases. J Assoc Physicians India (2012) 0.94
Systemic babesiosis. Another cause of the hemophagocytic syndrome. Am J Med (1986) 0.89
Tick-borne diseases in transfusion medicine. Transfus Med (2002) 0.88
Association between primary cytomegalovirus infection and severe hemolytic anemia in an immunocompetent adult. Eur J Clin Microbiol Infect Dis (1999) 0.85
Autoimmunity in transfusion babesiosis: a spectrum of clinical presentations. J Clin Apher (2010) 0.84
Clinicopatho-Biochemical Alterations Associated with Subclinical Babesiosis in Dairy Animals. J Arthropod Borne Dis (2016) 0.83
Persistence of babesiosis for >2 years in a patient on rituximab for rheumatoid arthritis. Diagn Microbiol Infect Dis (2016) 0.81
Haematologic complications from human babesiosis: a case report. New Microbes New Infect (2015) 0.81
Blood film findings in severe babesiosis. Br J Haematol (2015) 0.80
Autoimmune hemolytic anemia in a patient with Malaria. Asian J Transfus Sci (2013) 0.80
Comparison of a quantitative PCR assay with peripheral blood smear examination for detection and quantitation of Babesia microti infection in humans. Diagn Microbiol Infect Dis (2015) 0.79
Profound autoimmune hemolysis and Evans syndrome in two asplenic patients with babesiosis. Transfusion (2014) 0.78
Babesiasis (piroplasmosis) in dogs. J Am Vet Med Assoc (1957) 0.77
Hemophagocytic lymphohistiocytosis: macrophages engulfing red cells and neutrophils. Stem Cell Investig (2015) 0.77
Post-Babesiosis Warm Autoimmune Hemolytic Anemia. N Engl J Med (2017) 0.77
Babesiosis-associated immune thrombocytopenia. Stem Cell Investig (2017) 0.76
Complete remission after single agent blinatumomab in a patient with pre-B acute lymphoid leukemia relapsed and refractory to three prior regimens: hyperCVAD, high dose cytarabine mitoxantrone and CLAG. Exp Hematol Oncol (2016) 0.78
SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome. Biomark Res (2017) 0.75